VEGF and Id-1 in pancreatic adenocarcinoma: Prognostic significance and impact on angiogenesis

European Journal of Surgical Oncology

Volumn 40, Issue 10, 2014, Pages 1331-1337

  Georgiadou, D ^a   Sergentanis, T N ^b   Sakellariou, S ^c   Filippakis, G M ^d   Zagouri, F ^d   Vlachodimitropoulos, D ^b   Psaltopoulou, T ^b   Lazaris, A C ^c   Patsouris, E ^c   Zografos, G C ^d  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Id 1; Image analysis; MVD; Pancreatic adenocarcinoma; VEGF

Indexed keywords

CD34 ANTIGEN; INHIBITOR OF DIFFERENTIATION 1; VASCULOTROPIN; ID1 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ANGIOGENESIS; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CAPILLARY DENSITY; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MINIMAL RESIDUAL DISEASE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; TISSUE SECTION; ADENOCARCINOMA; AGED; CANCER STAGING; COHORT ANALYSIS; METABOLISM; MICROVASCULATURE; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; VASCULARIZATION;

ADENOCARCINOMA; AGED; ANTIGENS, CD34; CARCINOMA, PANCREATIC DUCTAL; COHORT STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84925226151     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2014.01.004     Document Type: Article

References (30)

1. M. Hidalgo Pancreatic cancer N Engl J Med 362 2010 1605 1617
2. T. Veikkola, M. Karkkainen, L. Claesson-Welsh, and K. Alitalo Regulation of angiogenesis via vascular endothelial growth factor receptors Cancer Res 60 2000 203 212
3. S.R. Wedge, J. Kendrew, and L.F. Hennequin et al. AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer Cancer Res 65 2005 4389 4400
4. R.A. Brekken, J.P. Overholser, V.A. Stastny, J. Waltenberger, J.D. Minna, and P.E. Thorpe Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice Cancer Res 60 2000 5117 5124
5. H.C. Sun, Z.J. Qiu, and J. Liu et al. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis Int J Oncol 30 2007 1359 1367
6. C. Huang, R. Huang, and W. Chang et al. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma Neoplasma 59 2012 52 61
7. S. Fujioka, K. Yoshida, S. Yanagisawa, M. Kawakami, T. Aoki, and Y. Yamazaki Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival Cancer 92 2001 1788 1797
8. Y.J. Lim, J.K. Lee, and C.K. Park et al. Prognostic value of VEGF in human pancreatic ductal adenocarcinoma Korean J Intern Med 19 2004 10 14
9. H.L. Kindler, K. Wroblewski, and J.A. Wallace et al. Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium Invest New Drugs 30 2010 382 386
10. Y.C. Wong, X. Wang, and M.T. Ling Id-1 expression and cell survival Apoptosis 9 2004 279 289
11. M.T. Ling, X. Wang, X. Zhang, and Y.C. Wong The multiple roles of Id-1 in cancer progression Differentiation 74 2006 481 487
12. S. Fong, R.J. Debs, and P.Y. Desprez Id genes and proteins as promising targets in cancer therapy Trends Mol Med 10 2004 387 392
13. T.K. Lee, R.T. Poon, and A.P. Yuen et al. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma Clin Cancer Res 12 2006 6910 6919
14. P.B. Vermeulen, G. Gasparini, and S.B. Fox et al. Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours Eur J Cancer 38 2002 1564 1579
15. V.V. Iakovlev, M. Gabril, and W. Dubinski et al. Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study Lab Invest 92 2011 46 56
16. M. Niedergethmann, R. Hildenbrand, and B. Wostbrock et al. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas Pancreas 25 2002 122 129
17. A.A. Khorana, S.A. Ahrendt, and C.K. Ryan et al. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer Clin Cancer Res 13 2007 2870 2875
18. L.M. Ellis, Y. Takahashi, C.J. Fenoglio, K.R. Cleary, C.D. Bucana, and D.B. Evans Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma Eur J Cancer 34 1998 337 340
19. Y. Seo, H. Baba, T. Fukuda, M. Takashima, and K. Sugimachi High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma Cancer 88 2000 2239 2245
20. N. Ikeda, M. Adachi, and T. Taki et al. Prognostic significance of angiogenesis in human pancreatic cancer Br J Cancer 79 1999 1553 1563
21. M.J. Waldner, and M.F. Neurath Targeting the VEGF signaling pathway in cancer therapy Expert Opin Ther Targets 16 2012 5 13
22. M. Fukasawa, and M. Korc Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines Clin Cancer Res 10 2004 3327 3332
23. T. Hoshida, M. Sunamura, and D.G. Duda et al. Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor Pancreas 25 2002 111 121
24. E.M. O'Reilly Pancreatic adenocarcinoma: new strategies for success Gastrointest Cancer Res 3 2009 S11 S15
25. D. Cao, R. Ashfaq, M.G. Goggins, R.H. Hruban, S.E. Kern, and C.A. Iacobuzio-Donahue Differential expression of multiple genes in association with MADH4/DPC4/SMAD4 inactivation in pancreatic cancer Int J Clin Exp Pathol 1 2008 510 517
26. K.T. Lee, Y.W. Lee, and J.K. Lee et al. Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers Br J Cancer 90 2004 1198 1203
27. H. Maruyama, J. Kleeff, and S. Wildi et al. Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis Am J Pathol 155 1999 815 822
28. H.Y. Yang, H.L. Liu, and G.Y. Liu et al. Expression and prognostic values of Id-1 and Id-3 in gastric adenocarcinoma J Surg Res 167 2010 258 266
29. M.T. Ling, T.C. Lau, and C. Zhou et al. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF) Carcinogenesis 26 2005 1668 1676
30. S. Fong, Y. Itahana, and T. Sumida et al. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis Proc Natl Acad Sci U S A 100 2003 13543 13548